Spirytus hibitanowy 0.5% ats

Poland
Brand name Spirytus hibitanowy 0.5% ats
Form solution for skin
Active substance / Dosage
Prescription type Over-the-counter
ATC code
Registration number 100138066
Spirytus hibitanowy 0.5% ats solution for skin

INFORMATION ON IMMEDIATE PACKAGING
Plastic bottle

1. NAME OF THE MEDICINAL PRODUCT

SPIRYTUS HIBITANOWY 0,5% ATS, skin solution

2. COMPOSITION OF ACTIVE SUBSTANCE

100 g of skin solution contains 0.5 g of chlorhexidine digluconate.

3. LIST OF EXCIPIENTS

Ethanol 760 g/l, purified water

4. PHARMACEUTICAL FORM AND PACKAGE CONTENTS

Skin solution
100 ml EAN code: 5909990072958
500 ml EAN code: 5909990072965
600 ml EAN code: 5909990072972
1000 ml EAN code: 5909990072989

5. METHOD AND ROUTE OF ADMINISTRATION

For topical use on the skin.
Indication: an antiseptic solution intended for disinfection of the hands of medical personnel,
patient's skin, and the surgical site prior to procedures.

6. WARNING ON STORAGE OF THE MEDICINAL PRODUCT

KEEP OUT OF SIGHT AND REACH OF CHILDREN
The justification for not including an entry in point 6, provided by the responsible party, has been accepted.

7. OTHER SPECIAL WARNINGS, IF NECESSARY

Contraindications: do not use in case of diagnosed hypersensitivity to chlorhexidine digluconate,
on burns and open wounds, or for disinfection of mucous membranes.
Do not use in infants and young children.

8. EXPIRY DATE

Expiry date (EXP):

9. STORAGE CONDITIONS

Store below 25°C.
Protect from light. Store in tightly closed containers.

10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED

MEDICINAL PRODUCT OR WASTE DERIVING FROM IT, IF APPROPRIATE
The justification for not including information in section 10 has been accepted by the responsible entity.

11. NAME AND ADDRESS OF THE RESPONSIBLE ENTITY

Laboratorium Farmaceutyczne „Labpharm-ATS” Anna Szost, Tadeusz Szost
ul. Mickiewicza 32
05-840 Brwinów

12. MARKETING AUTHORISATION NUMBER

Authorisation No. IL-4289/ZF

13. BATCH NUMBER

Batch number:

14. AVAILABILITY CATEGORY

OTC - Medicinal product available without a doctor's prescription.

15. INSTRUCTIONS FOR USE

Use without dilution.

16. INFORMATION PROVIDED IN BRAILLE

The justification provided by the marketing authorization holder for the absence of Braille labelling has been accepted.